The Ukrainian pharmaceutical group of companies Yuria-Pharm is considering the possibility of localizing vaccine production in Ukraine.
A prerequisite for the development of the production of biotechnological products was the developments of its own Biotech R&D, in particular, a technological platform for the development and pilot production of recombinant protein products, monoclonal antibodies. In addition, hardware and the methodological base were established to ensure quality control of biopharmaceuticals and vaccines, both of our own production and solutions of contract partners.
Director-General of Yuria-Pharm Dmytro Derkach: “Five years ago, construction began on a new plant in Cherkasy with a total area of more than 25,000 square meters, which provides for high-tech aseptic production and production of biotechnological products. The workshops of the new production site have been launched starting in 2020.”
via Interfax-Ukraine, Ukraine OPEN for business